Hemophagocytic Lymphohistiocytosis That Developed Soon After the Initial Administration of Atezolizumab, Which Is an Anti-PD-L1 Antibody Drug, and Thereafter Deteriorated Rapidly: an Autopsy Case | Zendy

AI Assistant Blog Pricing

Hemophagocytic Lymphohistiocytosis That Developed Soon After the Initial Administration of Atezolizumab, Which Is an Anti-PD-L1 Antibody Drug, and Thereafter Deteriorated Rapidly: an Autopsy Case

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.